Behance Facebook Instagram Linkedin Twitter Vimeo VKontakte Youtube
Sign in
  • Home
  • Biotech News
  • Conferences
    • Technology Conferences
    • Biotech Conferences
  • CoronaVirus
    • Precision Vaccinations
  • Internet News
  • Research
  • Reverse Splits
    • Reverse Split News
    • Reverse Split Watch List
    • Reverse Stock Split List
    • Upcoming Reverse Stock Split List
  • More Finance Channels
    • Beverage Stocks
    • Blockchain Stocks
    • Gold Stocks
    • Marijuana Stocks
    • Psychedelic Stocks
    • Stand Down – Wall Street Bears
    • Tiki Hut Fund
Sign in
Welcome!Log into your account
Forgot your password?
Privacy Policy
Password recovery
Recover your password
Search
Thursday, May 29, 2025
  • Sign in / Join
  • Contact Us
  • Featured News
  • Free Weekly Newsletter
Behance Facebook Instagram Linkedin Twitter Vimeo VKontakte Youtube
Sign in
Welcome! Log into your account
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
A password will be e-mailed to you.
Internet | Biotech Stock Review
  • Home
  • Biotech News
  • Conferences
    • Technology Conferences
    • Biotech Conferences
  • CoronaVirus
    • Precision Vaccinations
  • Internet News
  • Research
  • Reverse Splits
    • Reverse Split News
    • Reverse Split Watch List
    • Reverse Stock Split List
    • Upcoming Reverse Stock Split List
  • More Finance Channels
    • Beverage Stocks
    • Blockchain Stocks
    • Gold Stocks
    • Marijuana Stocks
    • Psychedelic Stocks
    • Stand Down – Wall Street Bears
    • Tiki Hut Fund
Home Biotech News 2020 Watch List Dyadic (DYAI) Price Target $12.
Dyadic, Biotech Stock Review
  • Biotech News
  • 2020 Watch List
  • All News
  • Client
  • CoronaVirus
  • Research
  • Superbug News - CoronaVirus Watch List

Dyadic (DYAI) Price Target $12.

By
Editor / Curator
-
November 6, 2020
Facebook
Twitter
Pinterest
Linkedin
Email
    • TAGS
    • DYAI
    Facebook
    Twitter
    Pinterest
    Linkedin
    Email
      Previous articleDalrada (DFCO) Removes Shell Company Status.
      Next articleAdding Galaxy Digital (GLXY) $5.19 to Watch List.
      Editor / Curator
      Editor / Curator

      RELATED ARTICLESMORE FROM AUTHOR

      2023 Watch List

      Cardiol Therapeutics (CRDL) May 2025 Presentation.

      All News

      Nice Bounce on Alkaline Water (WTER) up 81%.

      All News

      Gold prices plunge in biggest one-day drop in years. Is the record rally over? (MW)

      All News

      Gold Price Sets New Intraday Record Above $3,500 (WSJ)

      All News

      Gold Surges to a Record Above $3,400 as Trump threatens Fed Independence (CNBC)

      All News

      Epidemic Denial: RFK Jr. Holds Press Conference on new Autism findings from the CDC

      Reverse Stock Split, Watch List

      Plan Your Day Wisely

      May 2025
      M T W T F S S
       1234
      567891011
      12131415161718
      19202122232425
      262728293031  
      « Apr    

      Learn Investing From Billionaires (Free)

      Reverse Stock Split News

      Institutional Gold Research

      Latest article

      Cardiol Therapeutics (CRDL) May 2025 Presentation.

      2023 Watch List Editor / Curator - May 15, 2025
      Click here to open. RELATED: Cardiol’s (CRDL) Game-Changing Solution for Heart Inflammation? | David Elsley CEO – Video Interview

      Nice Bounce on Alkaline Water (WTER) up 81%.

      All News Editor / Curator - May 14, 2025
      Well now that ain't bad, up 81%! Our outlook on The Alkaline Water Company, our "comeback of the decade" story, is "let's see what...

      Zomedica Corp (ZOMDF) $0.05

      Uncategorized Editor / Curator - May 8, 2025
      Company Overview Background Zomedica Corp., incorporated in 2013 under the Business Corporations Act (Alberta), is headquartered in Ann Arbor, Michigan. Initially listed on the TSX Venture...
      Revelers.IO Finance Channel
      The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
      Contact us: roland@institutionalanalyst.com
      • Model Portfolio
      • Disclaimer
      • Contact us
      • Write For Us
      © Managed by Revelers.IO Media Group Inc.